Drug Name:
ZITHRANOL-RR Rx
Generic Name and Formulations:
Anthralin 1.2% (microcrystalline encapsulated); rapid-release cream.
Company:
Elorac Inc.
Therapeutic Use:
Indications for ZITHRANOL-RR:
Stable plaque psoriasis.
Adult:
Initially apply once daily (5–15 minutes contact time) for at least one week; may increase contact time to 30 minutes before washing off. Individualize. For skin: use sparingly. For scalp: wash and rinse hair; apply cream while hair is damp; may repeat treatment on alternate days.
Children:
Not recommended.
Contraindications:
Acute or actively inflamed psoriatic eruptions.
Warnings/Precautions:
Avoid eyes, mucous membranes. Apply cautiously on the face or intertriginous skin areas. Discontinue if sensitization or excessive irritation develops. May stain fabrics; avoid. Pregnancy (Cat.C). Nursing mothers.
Pharmacological Class:
Antipsoriatic.
Adverse Reactions:
Possible contact allergic reactions, discolored hair or fingernails.
How Supplied:
Cream—15g, 45g
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- HbA1c Levels Predictive of Liraglutide Treatment Response in T2D
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine